Mar. 31 – Traces of radioactive iodine-131 from Japan have been found in Russia’s Primorye region, the head of the local meteorological service, Boris Bulai, said on its web site.
“Its concentration is more than 100 times lower than the acceptable level, and thus presents no threat to people’s health,” he said.
Primorye is the southeasternmost region of Russia bordered by China, North Korea, and it also verges on the sea with Japan. Read the rest of this entry »
Mar. 23 – The U.S. industrial conglomerate 3M, formerly known as the Minnesota Mining and Manufacturing Company, plans to build local facilities in Russia’s Tyumen and Samara regions. The total investment is expected to be more than US$15 million, Reza Vaziri, 3M Russia chief said Tuesday to reporters.
The company’s facility in Tyumen will produce an insulation material Thinsulate — a very thin synthetic fiber thermal insulation fabric used in clothing. The other one in Samara will make glass bubbles used as an additive to cement that fortifies oil and gas wells. Read the rest of this entry »
Feb. 9 – More global drug makers will soon announce plans to establish a local presence in Russia in response to government measures to boost its domestic sector and cut dependence on imports, industry group Association of International Pharmaceutical Manufacturers (AIPM) said on Tuesday.
AIPM, whose members account for 80 percent of all global drug sales, had earlier promised US$1 billion in investments in Russian manufacturing, packaging and research and development. Read the rest of this entry »
Apr. 14 – Prime Minister Vladimir Putin and the government’s foreign investment commission on Tuesday approved a deal to sell a private insulin plant to Europe’s biggest drug maker, France-based Sanofi-Aventis.
The plant was bought in Oct 2009 from Bioton Vostok in Oryol region of Russian Federation which lies in 382 kilometers to the south of Moscow, in the European part of Russia.
Putin singled out the planned French investment as particularly noteworthy. “Among these, I want to point out one project that is not big but is significant, in my view,” he said, referring to Sanofi’s intention to buy 74 percent of the Bioton Vostok plant in Oryol. Read the rest of this entry »
Dezan Shira & Associates provide a range of services for companies looking to undertake foreign direct investment into Russia and Asia. These include corporate establishment, accounting, tax, payroll, audit and due diligence. To learn more about our practice, and our partner firm in Moscow and St.Petersburg, please contact us at russia@dezshira.com. Download our corporate brochure or visit at us www.dezshira.com.
